1Y Annualised Return
▲64.46%
3Y Annualised Return
▲45.24%
5Y Annualised Return
▲44.47%
Fortis Healthcare Stock Performance
|
|
|
Fortis Healthcare Company background
Fortis Healthcare Overview
Fortis Healthcare Limited was incorporated on February 28, 1996, by the Singh brothers as an extension of their pharmaceutical legacy. The company is headquartered at the Fortis Memorial Research Institute in Gurgaon, with its registered office in Mohali, Punjab. It operates 36 healthcare facilities across India, Dubai, and Sri Lanka, offering a range of medical services. Fortis is listed on both the Bombay Stock Exchange (BSE: 532843) and the National Stock Exchange (NSE: FORTISEQ), and is backed by Malaysia’s IHH Healthcare.
Fortis Healthcare Business Segments and Revenue Model
Fortis Healthcare operates through three primary segments: hospitals, diagnostics, and pharmacies. The hospital division provides multi-specialty tertiary and quaternary care services including cardiology, oncology, orthopaedics, neurology, and more. The diagnostics arm, Agilus Diagnostics, offers pathology and imaging services through a broad network. Its pharmacy business supports the hospital ecosystem and generates additional retail revenue. The company earns primarily through inpatient and outpatient services, diagnostics, pharmacy sales, and day-care procedures. Medical tourism contributes to the revenue as international patients seek cost-effective, high-quality treatment across Fortis facilities.
Fortis Healthcare Key Milestones
- 1996: Incorporated and launched its first hospital in Mohali, Punjab
- 2005: Acquired Escorts Heart and Research Centre in Delhi
- 2007: Launched its IPO and got listed on BSE and NSE
- 2015: Fortis Hospital Noida won the National Energy Conservation Award
- 2015: Received the Golden Globe Tigers Award for patient safety initiatives
- 2018: Founders resigned amid financial issues; IHH Healthcare acquired a 31.1% stake
- 2019: Acquired RHT Health Trust assets worth approximately ₹4,650 crore
- 2023: Completed acquisition of Medeor Hospital in Manesar
- 2024: Announced acquisition of a 31% stake in Agilus Diagnostics
- 2025: Won seven International Medical Value Travel Awards for excellence in various specialties
Fortis Healthcare ESG and Sustainability
- Tracks energy and water usage across hospitals with 19 active efficiency initiatives
- Focuses on eco-friendly biomedical waste management and carbon footprint reduction
- Implements WHO surgical safety protocols to enhance patient care
- Each unit has designated ESG champions driving sustainable practices
- Long-term goal includes embedding sustainability into core operations by 2030
Fortis Healthcare Awards and Recognitions
- Won the Golden Globe Tigers Award for excellence in patient safety practices
- Received the National Energy Conservation Award for energy efficiency at the Noida hospital
- Honoured at the International Patient Safety Conference for innovation and leadership
- Secured seven awards at the Medical Value Travel Summit across key specialties like cardiology, oncology, and orthopaedics
As of 10 Jul, 2025, Fortis Healthcare share price is ₹773.4. The stock opened at ₹785 and had closed at ₹784.7 the previous day. During today’s trading session, Fortis Healthcare share price moved between ₹766.55 and ₹785.80, with an average price for the day of ₹776.17. Over the last 52 weeks, the stock has recorded a low of ₹456.55 and a high of ₹813.00. In terms of performance, Fortis Healthcare share price has increased by 12.6% over the past six months and has increased by 64.46% over the last year.
Over the past
Fortis Healthcare Fundamental
Market Cap (in crs)
58,392.24
Face Value
10
Turnover (in lacs)
12,758.72
Key Metrics
Fortis Healthcare Key Financials
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
| Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
2007.2 Cr | 1928.26 Cr | 1988.39 Cr | 1858.9 Cr | 1785.88 Cr |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
7849.69 Cr | 6931.17 Cr | 6359.35 Cr | 5744.95 Cr | 4076.68 Cr | 4684.96 Cr |
| Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
183.38 Cr | 252.24 Cr | 188.85 Cr | 173.39 Cr | 198.82 Cr |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
797.86 Cr | 635.71 Cr | 611.15 Cr | 765.8 Cr | -103.73 Cr | 79.32 Cr |
Fortis Healthcare Result Highlights
Result Summary
-
Fortis Healthcare Ltd reported a 7.9% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a - of -.
-
Its expenses for the quarter were down by 9.7% QoQ and - - YoY.
-
The net profit decreased 20.1% QoQ and - - YoY.
-
The earnings per share (EPS) of Fortis Healthcare Ltd stood at 2.4 during Q4FY25.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Fortis Healthcare Technical Analysis
Moving Averages Analysis
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 844224 Rs | 1682043 Rs |
Week Rs | 615369 Rs | 1195412 Rs |
Month Rs | 969594 Rs | 1628690 Rs |
Resistance & Support
Fortis Healthcare Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,05,811.13 | 6001 | 7635 | 7,469.00 | -2.57% | 6.23% | 4.58% | 15.18% | 87.10% | 0.38% | 81.62 | 49.49 | 12.11 | ||
40,261.12 | 1171 | 2370.2 | 1,969.20 | -2.05% | 7.34% | 50.14% | 59.56% | 208.82% | 0.23% | 93.39 | 49.49 | 18.42 | ||
602.35 | 31,082.08 | 315.5 | 675 | 610.00 | -5.25% | 5.02% | 18.91% | 76.83% | 212.94% | 19.77% | 5.28 | 49.49 | 7.52 | |
1,21,673.90 | 836.6 | 1314.3 | 1,247.40 | -3.59% | 5.43% | 8.84% | 39.48% | 241.78% | 0.12% | 161.07 | 49.49 | 14.68 | ||
712.00 | 28,565.92 | 412 | 715.7 | 708.35 | 4.06% | 6.34% | 9.88% | 65.01% | 198.04% | 0.00% | 96.85 | 49.49 | 13.17 | |
34,964.71 | 935.5 | 1328.8 | 1,278.70 | 9.97% | 8.86% | 21.37% | 4.41% | 0.00% | 0.04% | 70.14 | 49.49 | 10.00 |
Fortis Healthcare Share Price FAQs
What is Share Price of Fortis Healthcare ?
Fortis Healthcare share price is ₹771.55 in NSE and ₹772 in BSE as on 10/7/2025.
How has Fortis Healthcare shares performed in the past ?
Fortis Healthcare share price in the past 1-year return was 64.45. The Fortis Healthcare share hit a 1-year low of Rs. 456.55 and a 1-year high of Rs. 813.
What is the market cap of Fortis Healthcare ?
The market cap of Fortis Healthcare is Rs. 58392.24 Cr. as of 10/7/2025.
What is the current P/E ratio of Fortis Healthcare ?
The PE ratios of Fortis Healthcare is 454.88 as of 10/7/2025.
What is the current PB ratio of Fortis Healthcare ?
The PB ratios of Fortis Healthcare is 6.43 as of 10/7/2025
What is the Mutual Fund shareholding in Fortis Healthcare ?
The Mutual Fund Shareholding in Fortis Healthcare was 25.77% at the end of 10/7/2025.
How to buy Fortis Healthcare shares?
You can easily buy Fortis Healthcare shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Fortis Healthcare ?
The 52-week high and low of Fortis Healthcare share price is ₹813 and ₹456.55 as of 10/7/2025.
Please be aware that Fortis Healthcare stock prices are subject to continuous fluctuations due to various factors.